Top Markets
Coin of the day
Lisata Therapeutics, Inc. Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc.

LSTA
Rangering i aksjer #32451
Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on... Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies. These treatments are designed to either reverse disease progression or facilitate the repair of damaged bodily tissues. The company's product portfolio features several notable candidates: HONEDRA, which has received SAKIGAKE designation and is presently in Phase II clinical trials for critical limb ischemia; XOWNA, currently undergoing Phase IIb testing for coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy aimed at individuals with chronic kidney disease who are not yet on dialysis. Founded in 1980 and based in Basking Ridge, New Jersey, the company was initially known as NeoStem, Inc., then rebranded as Caladrius Biosciences, Inc. in June 2015, before assuming its present identity as Lisata Therapeutics, Inc. on September 15, 2022.
Aksjekurs
$1.11
Markedsverdi
$10.06M
Endring (1 dag)
1.38%
Endring (1 år)
-56.32%
Land
US
Handel Lisata Therapeutics, Inc. (LSTA)

Kategori

Historikk for aksjesplitt for Lisata Therapeutics, Inc. (LSTA)
Aksjen Lisata Therapeutics, Inc. (symbol: LSTA) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 18, 2026.
Én LSTA-aksje kjøpt før Aug 18, 2026 tilsvarer i dag 0 LSTA-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE